Goldman Sachs’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.7M | Sell |
1,391,327
-1,655,657
| -54% | -$78.4M | 0.01% | 1492 |
|
|
2025
Q4 | $137M | Buy |
3,046,984
+1,503,808
| +97% | +$69.6M | 0.02% | 810 |
|
|
2025
Q3 | $68.9M | Sell |
1,543,176
-358,692
| -19% | -$17.2M | 0.01% | 1187 |
|
|
2025
Q2 | $91.4M | Buy |
1,901,868
+983,213
| +107% | +$42.8M | 0.01% | 937 |
|
|
2025
Q1 | $36.9M | Sell |
918,655
-377,750
| -29% | -$15.9M | 0.01% | 1457 |
|
|
2024
Q4 | $59.4M | Buy |
1,296,405
+25,853
| +2% | +$1.16M | 0.01% | 1152 |
|
|
2024
Q3 | $59.6M | Buy |
1,270,552
+241,916
| +24% | +$11M | 0.01% | 1117 |
|
|
2024
Q2 | $43.5M | Buy |
+1,028,636
| New | +$45.1M | 0.01% | 1265 |
|
|
2024
Q1 | – | Sell |
-2,460,920
| Closed | -$113M | – | 5819 |
|
|
2023
Q4 | $113M | Buy |
2,460,920
+1,148,951
| +88% | +$48.9M | 0.02% | 723 |
|
|
2023
Q3 | $56.3M | Sell |
1,311,969
-1,610,412
| -55% | -$75.1M | 0.01% | 1033 |
|
|
2023
Q2 | $140M | Buy |
2,922,381
+114,844
| +4% | +$5.54M | 0.03% | 578 |
|
|
2023
Q1 | $137M | Sell |
2,807,537
-618,747
| -18% | -$31.5M | 0.03% | 562 |
|
|
2022
Q4 | $181M | Sell |
3,426,284
-211,435
| -6% | -$10.4M | 0.04% | 455 |
|
|
2022
Q3 | $159M | Buy |
3,637,719
+290,263
| +9% | +$14.3M | 0.04% | 479 |
|
|
2022
Q2 | $168M | Buy |
3,347,456
+211,169
| +7% | +$10.3M | 0.04% | 467 |
|
|
2022
Q1 | $163M | Buy |
3,136,287
+247,591
| +9% | +$12.8M | 0.03% | 512 |
|
|
2021
Q4 | $170M | Buy |
2,888,696
+348,225
| +14% | +$20M | 0.03% | 522 |
|
|
2021
Q3 | $139M | Buy |
2,540,471
+931,959
| +58% | +$51.9M | 0.03% | 571 |
|
|
2021
Q2 | $82.5M | Sell |
1,608,512
-541,053
| -25% | -$27.9M | 0.02% | 862 |
|
|
2021
Q1 | $111M | Buy |
2,149,565
+911,873
| +74% | +$50.1M | 0.03% | 596 |
|
|
2020
Q4 | $69.4M | Sell |
1,237,692
-482,786
| -28% | -$25.8M | 0.02% | 866 |
|
|
2020
Q3 | $95.3M | Buy |
1,720,478
+610,383
| +55% | +$31.7M | 0.03% | 602 |
|
|
2020
Q2 | $50.4M | Sell |
1,110,095
-1,022,752
| -48% | -$45.8M | 0.02% | 948 |
|
|
2020
Q1 | $94.1M | Buy |
2,132,847
+873,156
| +69% | +$34.1M | 0.03% | 541 |
|
|
2019
Q4 | $45.1M | Sell |
1,259,691
-827,106
| -40% | -$30.7M | 0.01% | 1218 |
|
|
2019
Q3 | $73M | Buy |
2,086,797
+518,435
| +33% | +$19.9M | 0.02% | 848 |
|
|
2019
Q2 | $67.4M | Buy |
1,568,362
+690,548
| +79% | +$28.6M | 0.02% | 947 |
|
|
2019
Q1 | $37.9M | Sell |
877,814
-1,000,351
| -53% | -$40.2M | 0.01% | 1349 |
|
|
2018
Q4 | $68.6M | Buy |
1,878,165
+55,927
| +3% | +$2.08M | 0.02% | 850 |
|
|
2018
Q3 | $73.2M | Sell |
1,822,238
-645,008
| -26% | -$25.8M | 0.02% | 960 |
|
|
2018
Q2 | $94.6M | Sell |
2,467,246
-1,068,538
| -30% | -$39.3M | 0.03% | 779 |
|
|
2018
Q1 | $121M | Buy |
3,535,784
+767,918
| +28% | +$27M | 0.03% | 660 |
|
|
2017
Q4 | $90.8M | Buy |
2,767,866
+458,125
| +20% | +$15.8M | 0.02% | 858 |
|
|
2017
Q3 | $77.2M | Buy |
2,309,741
+15,488
| +0.7% | +$534K | 0.02% | 973 |
|
|
2017
Q2 | $81.6M | Buy |
2,294,253
+930,169
| +68% | +$31.4M | 0.02% | 908 |
|
|
2017
Q1 | $41.9M | Buy |
+1,364,084
| New | +$42M | 0.01% | 1342 |
|
Other funds holding QGEN
VCM
Goldman Sachs's QGEN Position: Q1 2026 in Review
Goldman Sachs reduced its Qiagen (QGEN) stake by 54% in Q1 2026, selling an estimated $78.4M and leaving 1,391,327 shares worth $55.7M. The position accounts for 0.01% of the portfolio, ranked #1492.
Goldman Sachs first reported a position in QGEN in Q1 2017 and has held it in 36 quarters since. The position peaked at $181M in Q4 2022. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.
- Goldman Sachs held 1,391,327 shares of Qiagen worth $55.7M as of Q1 2026.
- Goldman Sachs sold 1,655,657 Qiagen shares in Q1 2026, an estimated $78.4M.
- Qiagen made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1492 holding.
- Goldman Sachs first reported a position in Qiagen in Q1 2017 and has held it in 36 quarters since.
- Goldman Sachs's Qiagen position peaked at $181M in Q4 2022.
- 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.